Quick Answer
ORAGENICS INC reported Research And Development Expense of $2.39 million for the year ending 2025.
- ORAGENICS INC showed a decrease of -41.8% in Research And Development Expense from 2024 to 2025.
- This data is from ORAGENICS INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $465.5 thousand | Q3 2010: $463.4 thousand | Q1 2011: $412.9 thousand | Q2 2011: $631.4 thousand | Q3 2011: $562.7 thousand | Q1 2012: $353.2 thousand | Q2 2012: $6.18 million | Q3 2012: $600.2 thousand | Q1 2013: $745.4 thousand | Q2 2013: $637.0 thousand | Q3 2013: $6.91 million | Q1 2014: $1.02 million | Q2 2014: $903.3 thousand | Q3 2014: $597.0 thousand | Q1 2015: $676.6 thousand | Q2 2015: $5.61 million | Q3 2015: $1.10 million | Q1 2016: $1.22 million | Q2 2016: $792.7 thousand | Q3 2016: $924.8 thousand | Q1 2017: $1.12 million | Q2 2017: $605.4 thousand | Q3 2017: $996.5 thousand | Q1 2018: $1.33 million | Q2 2018: $1.27 million | Q3 2018: $1.58 million | Q1 2019: $2.41 million | Q2 2019: $3.88 million | Q3 2019: $3.07 million | Q1 2020: $3.71 million | Q2 2020: $11.54 million | Q3 2020: $3.50 million | Q1 2021: $3.26 million | Q2 2021: $2.47 million | Q3 2021: $3.55 million | Q1 2022: $3.29 million | Q2 2022: $2.59 million | Q3 2022: $2.78 million | Q1 2023: $1.67 million | Q2 2023: $2.01 million | Q3 2023: $769.4 thousand | Q1 2024: $663.4 thousand | Q2 2024: $906.8 thousand | Q3 2024: $879.0 thousand | Q1 2025: $341.5 thousand | Q2 2025: $449.7 thousand | Q3 2025: $930.9 thousand.
- Over the full 16 years of available data (2010 to 2025), ORAGENICS INC's Research And Development Expense has grown by 18.8%.
- Historical annual values: Fiscal year 2025: $2.39 million | Fiscal year 2024: $4.11 million | Fiscal year 2023: $15.49 million | Fiscal year 2022: $10.07 million | Fiscal year 2021: $10.59 million | Fiscal year 2020: $22.11 million | Fiscal year 2019: $12.12 million | Fiscal year 2018: $5.97 million | Fiscal year 2017: $3.54 million | Fiscal year 2016: $4.75 million | Fiscal year 2015: $8.73 million | Fiscal year 2014: $3.07 million | Fiscal year 2013: $9.36 million | Fiscal year 2012: $7.86 million | Fiscal year 2011: $2.45 million | Fiscal year 2010: $2.01 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: